The successful candidates will be nationally or internationally recognized investigators who have established independent and impactful research programs in areas relevant to genitourinary malignancies, with particular applicability to bladder and/or prostate cancer. This unique cluster hire—supported by the rich scientific environments of the Ohio State University Comprehensive Cancer Center (OSUCCC) and the College of Medicine, in partnership with a leading clinical department—offers an exceptional opportunity to leverage shared strengths in cancer biology, tumor immunology, comparative oncology, translational therapeutics, and investigator-initiated clinical trials. The initiative is intentionally cross-cutting, designed to foster synergy across departments and colleges, and to position The Ohio State University as a national leader in genitourinary cancer research and discovery.